Much ground already covered by joint assessments of EU notified bodies, but more needed
This article was originally published in Clinica
Executive Summary
Joint assessments by national designating authorities of notified bodies active in the medical device area are relatively new. A voluntary program related to these assessments kicked off in January 2013 and the initiative has already seen much action. While those orchestrating this program are pleased at what has been achieved, more intense scrutiny is on the way and the European Parliament wants even more. Amanda Maxwell reports
You may also be interested in...
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.